Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis

被引:92
|
作者
Marra, Alexandre R. [1 ,2 ,3 ]
Perencevich, Eli N. [1 ,3 ]
Nelson, Richard E. [4 ,5 ]
Samore, Matthew [4 ,5 ]
Khader, Karim [4 ,5 ]
Chiang, Hsiu-Yin [6 ]
Chorazy, Margaret L. [1 ]
Herwaldt, Loreen A. [1 ]
Diekema, Daniel J. [1 ]
Kuxhausen, Michelle F. [7 ]
Blevins, Amy [8 ]
Ward, Melissa A. [1 ]
McDanel, Jennifer S. [1 ]
Nair, Rajeshwari [1 ,3 ]
Balkenende, Erin [1 ]
Schweizer, Marin L. [1 ,3 ]
机构
[1] Univ Iowa, Dept Internal Med, Carver Coll Med, 200 Hawkins Dr, Iowa City, IA 52242 USA
[2] Hosp Israelita Albert Einstein, Div Med Practice, Sao Paulo, Brazil
[3] Iowa City VA Hlth Care Syst, Ctr Access & Delivery Res & Evaluat, Iowa City, IA USA
[4] Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA
[5] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA
[6] China Med Univ Hosp, Big Data Ctr, Taichung, Taiwan
[7] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[8] Indiana Univ Sch Med, Ruth Lilly Med Lib, Indianapolis, IN 46202 USA
关键词
LENGTH-OF-STAY; RESISTANT STAPHYLOCOCCUS-AUREUS; CARE-ASSOCIATED INFECTIONS; UNITED-STATES; HOSPITAL-ONSET; RISK-FACTORS; INCREASING INCIDENCE; CELL TRANSPLANT; TOTAL HIP; COSTS;
D O I
10.1001/jamanetworkopen.2019.17597
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Key PointsQuestionWhat is the incidence of hospital-onset Clostridium difficile infection (CDI) and its associated length of stay? FindingsThis systematic review and meta-analysis of 13 studies using patient-days as the denominator found that the incidence of hospital-onset CDI was 8.3 cases per 10000 patient-days. Among propensity score-matched studies of the length of stay, the mean difference in length of stay between patients with and those without CDI varied from 3.0 to 21.6 days. MeaningPooled estimates from currently available literature suggest that CDI is associated with a large burden on the US health care system. This systematic review and meta-analysis of 13 studies analyzes the incidence of Clostridium difficile infection and its associated hospital length of stay in the United States. ImportanceAn understanding of the incidence and outcomes of Clostridium difficile infection (CDI) in the United States can inform investments in prevention and treatment interventions. ObjectiveTo quantify the incidence of CDI and its associated hospital length of stay (LOS) in the United States using a systematic literature review and meta-analysis. Data SourcesMEDLINE via Ovid, Cochrane Library Databases via Wiley, Cumulative Index of Nursing and Allied Health Complete via EBSCO Information Services, Scopus, and Web of Science were searched for studies published in the United States between 2000 and 2019 that evaluated CDI and its associated LOS. Study SelectionIncidence data were collected only from multicenter studies that had at least 5 sites. The LOS studies were included only if they assessed postinfection LOS or used methods accounting for time to infection using a multistate model or compared propensity score-matched patients with CDI with control patients without CDI. Long-term-care facility studies were excluded. Of the 119 full-text articles, 86 studies (72.3%) met the selection criteria. Data Extraction and SynthesisTwo independent reviewers performed the data abstraction and quality assessment. Incidence data were pooled only when the denominators used the same units (eg, patient-days). These data were pooled by summing the number of hospital-onset CDI incident cases and the denominators across studies. Random-effects models were used to obtain pooled mean differences. Heterogeneity was assessed using the I-2 value. Data analysis was performed in February 2019. Main Outcomes and MeasuresIncidence of CDI and CDI-associated hospital LOS in the United States. ResultsWhen the 13 studies that evaluated incidence data in patient-days due to hospital-onset CDI were pooled, the CDI incidence rate was 8.3 cases per 10000 patient-days. Among propensity score-matched studies (16 of 20 studies), the CDI-associated mean difference in LOS (in days) between patients with and without CDI varied from 3.0 days (95% CI, 1.44-4.63 days) to 21.6 days (95% CI, 19.29-23.90 days). Conclusions and RelevancePooled estimates from currently available literature suggest that CDI is associated with a large burden on the health care system. However, these estimates should be interpreted with caution because higher-quality studies should be completed to guide future evaluations of CDI prevention and treatment interventions.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Association of Clostridium difficile infection in hospital mortality: A systematic review and meta-analysis
    Gao, Tianyi
    He, Bangshun
    Pan, Yuqin
    Deng, Qiwen
    Sun, Huiling
    Liu, Xian
    Chen, Jie
    Wang, Shukui
    Xia, Yongxiang
    AMERICAN JOURNAL OF INFECTION CONTROL, 2015, 43 (12) : 1316 - 1320
  • [32] Antimicrobial therapy of Clostridium difficile infection Systematic literature review and meta-analysis
    Brodszky, Valentin
    Gulacsi, Laszlo
    Ludwig, Endre
    Prinz, Gyula
    Banai, Janos
    Remenyi, Peter
    Strbak, Balint
    Kertesz, Adrienne
    Nemeth, Iren Kopcsone
    Urban, Edit Zsoldine
    Baji, Petra
    Pentek, Marta
    ORVOSI HETILAP, 2013, 154 (23) : 890 - 899
  • [33] Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis
    Kassam, Zain
    Lee, Christine H.
    Yuan, Yuhong
    Hunt, Richard H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (04): : 500 - 508
  • [34] Molecular Techniques for Diagnosis of Clostridium difficile Infection: Systematic Review and Meta-analysis
    O'Horo, John C.
    Jones, Amy
    Stemke, Matthew
    Harper, Christopher
    Safdar, Nasia
    MAYO CLINIC PROCEEDINGS, 2012, 87 (07) : 643 - 651
  • [35] Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection
    Li, Y. -T.
    Cai, H. -F.
    Wang, Z. -H.
    Xu, J.
    Fang, J. -Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (04) : 445 - 457
  • [36] Proton pump inhibitors and associated risk of Clostridium difficile infection: a systematic review and meta-analysis of observational studies
    Kwok, C. S.
    Arthur, A. K.
    Anibueze, C. I.
    Cavallazzi, R.
    Singh, S.
    Loke, Y. K.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (06) : 985 - 985
  • [37] Clostridioides (Clostridium) difficile infection in hospitalized patients with antibiotic-associated diarrhea: A systematic review and meta-analysis
    Nasiri, Mohammad Javad
    Goudarzi, Mehdi
    Hajikhani, Bahareh
    Ghazi, Mona
    Goudarzi, Hossein
    Pouriran, Ramin
    ANAEROBE, 2018, 50 : 32 - 37
  • [38] Gastric Acid Suppression and Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis
    Tariq, Raseen
    Singh, Siddharth
    Pardi, Darrell
    Khanna, Sahil
    GASTROENTEROLOGY, 2016, 150 (04) : S838 - S838
  • [39] Oral vancomycin prophylaxis for the prevention of Clostridium difficile infection: A systematic review and meta-analysis
    Babar, Sumbal
    El Kurdi, Bara
    El Iskandarani, Mahmoud
    Haddad, Ibrahim
    Imam, Zaid
    Alomari, Mohammad
    Myers, James
    Moorman, Jonathan
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (11): : 1302 - 1309
  • [40] Diagnostic test accuracy of glutamate dehydrogenase for Clostridium difficile: Systematic review and meta-analysis
    Jun Arimoto
    Nobuyuki Horita
    Shingo Kato
    Akiko Fuyuki
    Takuma Higurashi
    Hidenori Ohkubo
    Hiroki Endo
    Nonaka Takashi
    Takeshi Kaneko
    Atsushi Nakajima
    Scientific Reports, 6